MedTrace Logo

Translational Approaches to Septic Cardiomyopathy

NCT03252613 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2018-12-24

No results posted yet for this study

Summary

This translational study will assess the association between septic cardiomyopathy (measured via left ventricular global longitudinal strain) and (a) inflammatory cytokine profiles, and (b) the behavior of cardiomyocytes derived from inducible pluripotent stem cells.

Conditions

  • Cardiomyopathies
  • Sepsis
  • Septic Shock

Sponsors & Collaborators

  • Euan Ashley

    collaborator UNKNOWN

  • Samuel Brown

    lead OTHER

Principal Investigators

  • Samuel Brown, MD · Intermountain Health Care, Inc.

  • Euan Ashley, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-19
Primary Completion
2019-10-27
Completion
2019-10-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03252613 on ClinicalTrials.gov